antibody-drug conjugate abbv-324
Generic: Antibody-drug Conjugate ABBV-324
antibody-drug conjugate abbv-324: 1 clinical trial tracked.
antibody-drug conjugate abbv-324 evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about antibody-drug conjugate abbv-324, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trials (1)
A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV 324 in Adults With Hepatocellular Cancer or Squamous Cell Non-Small Cell Lung Cancer
Primary endpoint: Number of Participants with Adverse Events (AE)s
InterventionalRandomizedopen232 targetStarted 2025-04Completion 2030-0922 sites · China, Israel, Japan, Puerto Rico…AbbVie